Brief: Procter & Gamble Health Plans To Source Injections Portfolio Of Its Products From A Contract Manufacturer
Sept 27 (Reuters) - Procter & Gamble Health Ltd
PROR.NS :
* PLANS TO SOURCE INJECTIONS PORTFOLIO OF ITS PRODUCTS FROM
A
CONTRACT MANUFACTURER
* COMPANY SHALL DISCONTINUE PRODUCTION OF INJECTIONS AT ITS
MANUFACTURING PLANT IN GOA EFFECTIVE SEPT 30
* DISCONTINUATION OF PRODUCTION AT CO'S GOA PLANT SHALL NOT
HAVE
IMPACT ON CONTINUITY OF SALE OF INJECTIONS
Source text for Eikon: ID:nBSE4Vx6wn
Further company coverage: PROR.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Procter & Gamble Health
See all newsBrief: Procter & Gamble Health Says June-Quarter Net Profit 961.5 Million Rupees
India's Procter & Gamble Health set for best session in 7 years on Q4 profit jump
Advisory: Inadvertent alert on P&G-owned brand Always withdrawn
Brief: Procter & Gamble Health Dec-Quarter Net Profit 775.9 Million Rupees
Live Markets: When crypto prices tumbled, what of the corporate hoarders?